Charles River Laboratories
Joseph W. LaPlume joined Charles River in 2005, was named the Company’s Corporate Senior Vice President, Corporate Development in 2014, and promoted to Corporate Executive Vice President, Corporate Development & Strategy in 2019. Mr. LaPlume is responsible for strategic acquisitions and expanding the Company’s portfolio and geographic footprint. Mr. LaPlume was promoted from Corporate Vice President, Corporate Development, a position that he held from 2011, and has been instrumental in enhancing the Company’s growth profile through several acquisitions and multiple licensing transactions. Mr. LaPlume was formerly Deputy General Counsel at Charles River, and began his career at Charles River as a corporate lawyer in 2005. Prior to joining Charles River, Mr. LaPlume had extensive experience in both corporate law and mergers and acquisitions at Mintz Levin, Goulston & Storrs, and GTECH Corporation.
This person is not in any offices
Charles River Laboratories
15 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.